Published in Tissue Eng on December 01, 2002
Bone marrow mesenchymal stem cells: historical overview and concepts. Hum Gene Ther (2010) 1.63
Markers for characterization of bone marrow multipotential stromal cells. Stem Cells Int (2012) 1.59
Chondrogenic differentiation of amniotic fluid-derived stem cells. J Mol Histol (2007) 1.44
Fibroblast growth factor-2 enhances proliferation and delays loss of chondrogenic potential in human adult bone-marrow-derived mesenchymal stem cells. Tissue Eng Part A (2010) 1.38
Osterix enhances proliferation and osteogenic potential of bone marrow stromal cells. Biochem Biophys Res Commun (2006) 1.21
Osterix overexpression in mesenchymal stem cells stimulates healing of critical-sized defects in murine calvarial bone. Tissue Eng (2007) 1.14
Chondrogenic differentiation of bone marrow-derived mesenchymal stem cells: tips and tricks. Methods Mol Biol (2011) 1.14
Changes in culture expanded human amniotic epithelial cells: implications for potential therapeutic applications. PLoS One (2011) 1.11
Mesenchymal stem cells in the treatment of traumatic articular cartilage defects: a comprehensive review. Arthritis Res Ther (2014) 1.09
Regenerative therapy after cancer: what are the risks? Tissue Eng Part B Rev (2010) 1.01
Clonal multipotency and effect of long-term in vitro expansion on differentiation potential of human hair follicle derived mesenchymal stem cells. Stem Cell Res (2011) 1.01
Roles of SATB2 in osteogenic differentiation and bone regeneration. Tissue Eng Part A (2011) 0.99
Human fibroblasts share immunosuppressive properties with bone marrow mesenchymal stem cells. J Clin Immunol (2010) 0.96
Osteogenic predifferentiation of human bone marrow-derived stem cells by short-term mechanical stimulation. Open Orthop J (2011) 0.89
Expansion of human mesenchymal stromal cells from fresh bone marrow in a 3D scaffold-based system under direct perfusion. PLoS One (2014) 0.88
A p38 MAPK-mediated alteration of COX-2/PGE2 regulates immunomodulatory properties in human mesenchymal stem cell aging. PLoS One (2014) 0.88
Aging increases the susceptivity of MSCs to reactive oxygen species and impairs their therapeutic potency for myocardial infarction. PLoS One (2014) 0.82
Different tenogenic differentiation capacities of different mesenchymal stem cells in the presence of BMP-12. J Transl Med (2015) 0.82
TiO₂-doped phosphate glass microcarriers: a stable bioactive substrate for expansion of adherent mammalian cells. J Biomater Appl (2012) 0.81
Optimal Seeding Densities for In Vitro Chondrogenesis of Two- and Three-Dimensional-Isolated and -Expanded Bone Marrow-Derived Mesenchymal Stromal Stem Cells Within a Porous Collagen Scaffold. Tissue Eng Part C Methods (2016) 0.80
Are cultured mesenchymal stromal cells an option for immunomodulation in transplantation? Front Immunol (2013) 0.78
Inhibition of Transforming Growth Factor-β Receptor signaling promotes culture expansion of undifferentiated human Endometrial Mesenchymal Stem/stromal Cells. Sci Rep (2015) 0.78
Assessing adipogenic potential of mesenchymal stem cells: a rapid three-dimensional culture screening technique. Stem Cells Int (2013) 0.77
The Chondrogenic Potential of Mesenchymal Cells and Chondrocytes from Osteoarthritic Subjects: A Comparative Analysis. Cartilage (2011) 0.77
NGF and TERT co-transfected BMSCs improve the restoration of cognitive impairment in vascular dementia rats. PLoS One (2014) 0.77
Changes in Chondrogenic Progenitor Populations Associated with Aging and Osteoarthritis. Cartilage (2015) 0.75
Immortalisation with hTERT Impacts on Sulphated Glycosaminoglycan Secretion and Immunophenotype in a Variable and Cell Specific Manner. PLoS One (2015) 0.75
Predicting the Remaining Lifespan and Cultivation-Related Loss of Osteogenic Capacity of Bone Marrow Multipotential Stromal Cells Applicable across a Broad Donor Age Range. Stem Cells Int (2017) 0.75
The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med (2006) 6.90
Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood (2005) 3.71
Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis. Arthritis Rheum (2007) 3.08
A quantitative measurement of the human somatic mutation rate. Cancer Res (2005) 2.55
Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria. Blood (2007) 2.36
Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway. Eur J Immunol (2005) 2.34
Stem cells associated with macroporous bioceramics for long bone repair: 6- to 7-year outcome of a pilot clinical study. Tissue Eng (2007) 2.10
Human mesenchymal stem cells inhibit neutrophil apoptosis: a model for neutrophil preservation in the bone marrow niche. Stem Cells (2007) 1.94
Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2. Exp Cell Res (2003) 1.78
Rationale for recommending a lower dose of primaquine as a Plasmodium falciparum gametocytocide in populations where G6PD deficiency is common. Malar J (2012) 1.76
Complement fraction 3 binding on erythrocytes as additional mechanism of disease in paroxysmal nocturnal hemoglobinuria patients treated by eculizumab. Blood (2009) 1.59
Role of scaffold internal structure on in vivo bone formation in macroporous calcium phosphate bioceramics. Biomaterials (2006) 1.55
Peptide inhibitors of C3 activation as a novel strategy of complement inhibition for the treatment of paroxysmal nocturnal hemoglobinuria. Blood (2014) 1.55
Bone marrow stromal cells (BMSCs) in bone engineering: limitations and recent advances. Ann Biomed Eng (2004) 1.54
LRF is an essential downstream target of GATA1 in erythroid development and regulates BIM-dependent apoptosis. Dev Cell (2009) 1.39
Three-dimensional perfusion culture of human bone marrow cells and generation of osteoinductive grafts. Stem Cells (2005) 1.32
Maternally transmitted severe glucose 6-phosphate dehydrogenase deficiency is an embryonic lethal. EMBO J (2002) 1.30
Glucose 6-phosphate dehydrogenase deficiency: from genotype to phenotype. Haematologica (2006) 1.24
Osteoinduction of human mesenchymal stem cells by bioactive composite scaffolds without supplemental osteogenic growth factors. PLoS One (2011) 1.23
Comparative evaluation of autologous chondrocyte implantation and mosaicplasty: a multicentered randomized clinical trial. Clin J Sport Med (2005) 1.20
Management of paroxysmal nocturnal haemoglobinuria: a personal view. Br J Haematol (2011) 1.19
Clinical spectrum and severity of hemolytic anemia in glucose 6-phosphate dehydrogenase-deficient children receiving dapsone. Blood (2012) 1.16
Tumor necrosis factor-alpha (TNF-alpha) induces integrin CD11b/CD18 (Mac-1) up-regulation and migration to the CC chemokine CCL3 (MIP-1alpha) on human neutrophils through defined signalling pathways. Cell Signal (2007) 1.16
Tissue engineering and cell therapy of cartilage and bone. Matrix Biol (2003) 1.15
Development of sarcomas in mice implanted with mesenchymal stem cells seeded onto bioscaffolds. Carcinogenesis (2008) 1.15
The mutation rate in PIG-A is normal in patients with paroxysmal nocturnal hemoglobinuria (PNH). Blood (2006) 1.15
Orderly osteochondral regeneration in a sheep model using a novel nano-composite multilayered biomaterial. J Orthop Res (2010) 1.14
New small nuclear RNA gene-like transcriptional units as sources of regulatory transcripts. PLoS Genet (2006) 1.14
The development of tissue-engineered bone of different origin through endochondral and intramembranous ossification following the implantation of mesenchymal stem cells and osteoblasts in a murine model. Biomaterials (2009) 1.14
Excellent prognosis and prevalence of HCV infection of primary hepatic and splenic non-Hodgkin's lymphoma. Eur J Haematol (2008) 1.14
Design of graded biomimetic osteochondral composite scaffolds. Biomaterials (2008) 1.12
The recruitment of two consecutive and different waves of host stem/progenitor cells during the development of tissue-engineered bone in a murine model. Biomaterials (2009) 1.12
Targeted expression of SHH affects chondrocyte differentiation, growth plate organization, and Sox9 expression. J Bone Miner Res (2004) 1.10
Recruitment of a host's osteoprogenitor cells using exogenous mesenchymal stem cells seeded on porous ceramic. Tissue Eng Part A (2009) 1.09
An Alu-like RNA promotes cell differentiation and reduces malignancy of human neuroblastoma cells. FASEB J (2010) 1.08
17A, a novel non-coding RNA, regulates GABA B alternative splicing and signaling in response to inflammatory stimuli and in Alzheimer disease. Neurobiol Dis (2010) 1.07
Cell therapy for bone disease: a review of current status. Stem Cells (2003) 1.07
A cell-free scaffold-based cartilage repair provides improved function hyaline-like repair at one year. Clin Orthop Relat Res (2011) 1.06
Response of young, aged and osteoarthritic human articular chondrocytes to inflammatory cytokines: molecular and cellular aspects. Matrix Biol (2002) 1.06
Cartilage and bone extracellular matrix. Curr Pharm Des (2009) 1.06
Multiplex tetra-primer amplification refractory mutation system PCR to detect 6 common germline mutations of the MUTYH gene associated with polyposis and colorectal cancer. Clin Chem (2006) 1.05
Neutral evolution in paroxysmal nocturnal hemoglobinuria. Proc Natl Acad Sci U S A (2008) 1.05
Selection of candidate housekeeping genes for normalization in human postmortem brain samples. Int J Mol Sci (2011) 1.05
Polymorphism of the complement receptor 1 gene correlates with the hematologic response to eculizumab in patients with paroxysmal nocturnal hemoglobinuria. Haematologica (2013) 1.04
p38/NF-kB-dependent expression of COX-2 during differentiation and inflammatory response of chondrocytes. J Cell Biochem (2008) 1.04
Bone marrow stromal cells and their use in regenerating bone. Novartis Found Symp (2003) 1.03
Reconstruction of extensive long bone defects in sheep using resorbable bioceramics based on silicon stabilized tricalcium phosphate. Tissue Eng (2006) 1.03
Mesenchymal stem cells induce functionally active T-regulatory lymphocytes in a paracrine fashion and ameliorate experimental autoimmune uveitis. Invest Ophthalmol Vis Sci (2012) 1.02
NDM29, a RNA polymerase III-dependent non coding RNA, promotes amyloidogenic processing of APP and amyloid β secretion. Biochim Biophys Acta (2012) 1.02
Induction of neutrophil chemotaxis by leptin: crucial role for p38 and Src kinases. Ann N Y Acad Sci (2006) 1.02
Formation of a chondro-osseous rudiment in micromass cultures of human bone-marrow stromal cells. J Cell Sci (2003) 1.02
RNA polymerase III drives alternative splicing of the potassium channel-interacting protein contributing to brain complexity and neurodegeneration. J Cell Biol (2011) 1.01
Paroxysmal nocturnal hemoglobinuria and eculizumab. Haematologica (2010) 1.00
Depletion of cartilage collagen fibrils in mice carrying a dominant negative Col2a1 transgene affects chondrocyte differentiation. Am J Physiol Cell Physiol (2003) 0.99
Severe telomere shortening in patients with paroxysmal nocturnal hemoglobinuria affects both GPI- and GPI+ hematopoiesis. Blood (2003) 0.99
Dichloroacetate inhibits neuroblastoma growth by specifically acting against malignant undifferentiated cells. Int J Cancer (2011) 0.99
Transcriptional functionality of germ line p53 mutants influences cancer phenotype. Clin Cancer Res (2007) 0.99
Glycosylphosphatidylinositol-linked proteins are required for maintenance of a normal peripheral lymphoid compartment but not for lymphocyte development. Eur J Immunol (2002) 0.98
Amniotic liquid derived stem cells as reservoir of secreted angiogenic factors capable of stimulating neo-arteriogenesis in an ischemic model. Biomaterials (2011) 0.98
Glycosylphosphatidylinositol-specific, CD1d-restricted T cells in paroxysmal nocturnal hemoglobinuria. Blood (2013) 0.98
An interaction between hepatocyte growth factor and its receptor (c-MET) prolongs the survival of chronic lymphocytic leukemic cells through STAT3 phosphorylation: a potential role of mesenchymal cells in the disease. Haematologica (2011) 0.97
Bone turnover in wild type and pleiotrophin-transgenic mice housed for three months in the International Space Station (ISS). PLoS One (2012) 0.97
Carrageenan-based hydrogels for the controlled delivery of PDGF-BB in bone tissue engineering applications. Biomacromolecules (2009) 0.95
Acquisition of neuron-like electrophysiological properties in neuroblastoma cells by controlled expression of NDM29 ncRNA. J Neurochem (2011) 0.95
Analysis of gene expression profiles reveals novel correlations with the clinical course of colorectal cancer. Oncol Res (2007) 0.94
CD157 is an important mediator of neutrophil adhesion and migration. Blood (2004) 0.94
Highly homologous T-cell receptor beta sequences support a common target for autoreactive T cells in most patients with paroxysmal nocturnal hemoglobinuria. Blood (2007) 0.94
Dual effect of platelet lysate on human articular cartilage: a maintenance of chondrogenic potential and a transient proinflammatory activity followed by an inflammation resolution. Tissue Eng Part A (2013) 0.93
The role of bFGF on the ability of MSC to activate endogenous regenerative mechanisms in an ectopic bone formation model. Biomaterials (2011) 0.93
Pregnancy in PNH: another eculizumab baby. Br J Haematol (2010) 0.93
The use of PIG-A as a sentinel gene for the study of the somatic mutation rate and of mutagenic agents in vivo. Mutat Res (2009) 0.93
CD157 plays a pivotal role in neutrophil transendothelial migration. Blood (2006) 0.91
Galline Ex-FABP is an antibacterial siderocalin and a lysophosphatidic acid sensor functioning through dual ligand specificities. Structure (2011) 0.91
High incidence of thrombosis in African-American and Latin-American patients with Paroxysmal Nocturnal Haemoglobinuria. Thromb Haemost (2005) 0.91
An intronic ncRNA-dependent regulation of SORL1 expression affecting Aβ formation is upregulated in post-mortem Alzheimer's disease brain samples. Dis Model Mech (2012) 0.91